Skip to main content

Advertisement

Table 2 Chemotherapy regimens of the MDR-TB patients

From: Factors affecting time to sputum culture conversion and treatment outcome of patients with multidrug-resistant tuberculosis in China

Variable Chemotherapy regimen N (%)
Individualized regimen Distinct from patient-to-patient 63 (45.3%)
Regimen 1 6 Pyrazinamide Amikacin Levofloxacin Cycloserine Protionamide 42 (30.2%)
/18 Pyrazinamide Levofloxacin Cycloserine Protionamide
Regimen 2 6 Pyrazinamide Amikacin Levofloxacin Para-amino salicylic acid Protionamide 16 (11.5%)
/18 Pyrazinamide Levofloxacin Para-amino salicylic acid Protionamide
Regimen 3 6 Pyrazinamide Capreomycin Levofloxacin Cycloserine Protionamide 3 (2.2%)
/18 Pyrazinamide Levofloxacin Cycloserine Protionamide
Regimen 4 6 Pyrazinamide Capreomycin Levofloxacin Para-amino salicylic acid Protionamide 15 (10.8%)
/18 Pyrazinamide Levofloxacin Cycloserine Protionamide
  1. Abbreviations: MDR-TB multidrug-resistant tuberculosis, N number